Condition: Chronic Granulomatous Disease (CGD) · Sponsor: Ensoma
This research study is designed to assess the prevalence of specific antibodies and inflammatory cytokines in adult and pediatric participants with CGD.
This description comes directly from the study's public registry record.
Andrew Dietz, MD, MSCR · 617-766-3917 · ddietz@ensoma.com
Always discuss trial participation with your own doctor first.
| Home-based telemedicine | Montgomery, Alabama, United States | Recruiting |
| Home-based telemedicine | Phoenix, Arizona, United States | Recruiting |
| Home-based telemedicine | Little Rock, Arkansas, United States | Recruiting |
| Home-based telemedicine | Sacramento, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Home-based telemedicine | Denver, Colorado, United States | Recruiting |
| Home-based telemedicine | Hartford, Connecticut, United States | Recruiting |
| Home-based telemedicine | Dover, Delaware, United States | Recruiting |
| Home-based telemedicine | Washington D.C., District of Columbia, United States | Recruiting |
| Home-based telemedicine | Tallahassee, Florida, United States | Recruiting |
| Home-based telemedicine | Atlanta, Georgia, United States | Recruiting |
| Home-based telemedicine | Boise, Idaho, United States | Recruiting |
+ 40 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06605378